TREVENA INC
Pharmaceutical Preparations · 2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
공식 등기 데이터
0팔로워
2007설립
TREVENA INC 소개
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors (GPCR) biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz, winner of the 2012 Nobel Prize in Chemistry, and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Source: Wikipedia
산업Pharmaceutical Preparations
본사2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
설립2007
법적 형태C Corporation
상태운영 중
특허특허 10건
METHODS OF TREATING EPILEPSY USING THE SAMEJP2025138744A · 2025
COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAMEJP2023078375A · 2023
주요 수치
법적 정보
| 법인명 | TREVENA INC |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1429560SEC EDGAR에서 보기 ↗ |
| EIN | 26-1469215 |
| 업종 코드(SIC) | 2834 |
| 등기 주소 | 2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청